91九色视频

header-logo
Physician Patient
Psychiatry and Behavioral Medicine
Jennifer Knight, MD

Jennifer Knight, MD, MS, FACLP

Professor, Psychiatry and Behavioral Medicine and Microbiology & Immunology

Locations

  • Psychiatry and Behavioral Medicine

Contact Information

Learn more about the Knight Biobehavioral Oncology Laboratory

Biography

Dr. Knight completed her undergraduate training at the University of Wisconsin-Madison and her medical training at the 91九色视频. She completed her residency training in a combined Internal Medicine and Psychiatry program at Rush University in Chicago, and is double board certified in both specialties. She also completed a post-doctoral research fellowship in psychoneuroimmunology at the University of Rochester Medical Center.

Honors and Awards

1. Hilldale Research Fellowship, University of Wisconsin 鈥� Madison, Madison WI (1998)
2. Houghton Award, Wisconsin Medical Society (2004)
*Given to a medical student demonstrating excellence in socioeconomic and scientific medical issues
3. Applause Award, Department of Psychiatry, Rush University Medical Center, Chicago, IL (2005)
*Awarded to resident for excellence in patient care
4. Martin Fenton Award for Outstanding Medicine/Psychiatry Resident, The Association of Medicine and Psychiatry (2008)
5. William Webb Research Fellowship, Academy of Psychosomatic Medicine (2009-2010)
6. Medical Fellow Travel Scholarship Award, American Psychosomatic Society (2010)
7. Young Scholar Award, American Psychosomatic Society (2011)
8. Fellowship status, Academy of Consultation Liaison Psychiatry (FACLP) (2014)
9. Community of Innovators Award, 91九色视频, Milwaukee, WI (2018)
*Awarded to an 91九色视频 faculty member in acknowledgement of extraordinary passion, leadership, and efforts in innovation to better serve our students, patients, and communities
10. Woman Rising Pioneer in Research Award Nominee (2018-2019)
11. Elected Fellow, Academy of Behavioral Medicine Research (2019)
*Premier honorary scientific organization for scientists working at the interface of behavior and medicine
12. Dlin-Fischer Clinical Research Award (2023)
*Given to the author of the paper judged to be the most outstanding submission to the ACLP annual meeting

Research Interests

Dr. Knight’s research interests involve investigating the physiologic and immunologic effects that account for the relationship between psychosocial factors and clinical outcomes in hematopoietic stem cell transplant recipients. Clinically, she is the Medical Director of the Psycho-Oncology Program at Froedtert and 91九色视频 and specializes in general and psycho-oncology psychosomatic medicine consultation. She sees patients at the 91九色视频 Cancer Center and at Froedtert Hospital. She is on faculty at the Neuroscience Research Center and is also a Clinical Member of the 91九色视频 Cancer Center in the Transplantation Biology and Immunotherapy Research Program.

Publications

  • (Taylor MR, Cole SW, Bradford MC, Zhou C, Fladeboe KM, Knight JM, Baker KS, Yi-Frazier JP, Rosenberg AR.) Transplant Cell Ther. 2024 Dec;30(12):1209.e1-1209.e7 PMID: 39303988 SCOPUS ID: 2-s2.0-85205689086 09/21/2024

  • (Ballen K, Wang T, He N, Knight JM, Hong S, Frangoul H, Verdonck LF, Steinberg A, Diaz MA, LeMaistre CF, Badawy SM, Pu JJ, Hashem H, Savani B, Sharma A, Lazarus HM, Abid MB, Tay J, Rangarajan HG, Kindwall-Keller T, Freytes CO, Beitinjaneh A, Winestone LE, Gergis U, Farhadfar N, Bhatt NS, Schears RM, Gómez-Almaguer D, Aljurf M, Agrawal V, Kuwatsuka Y, Seo S, Marks DI, Lehmann L, Wood WA, Hashmi S, Saber W.) Transplant Cell Ther. 2024 Oct;30(10):1027.e1-1027.e14 PMID: 39033978 SCOPUS ID: 2-s2.0-85200332491 07/22/2024

  • (Lahijani S, Rueda-Lara M, McAndrew N, Nelson AM, Guo M, Knight JM, Wiener L, Miran DM, Gray TF, Keane EP, Yek MH, Sannes TS, Applebaum AJ, Fank P, Babu P, Pozo-Kaderman C, Amonoo HL.) Transplant Cell Ther. 2024 Sep;30(9S):S493-S512 PMID: 39370233 SCOPUS ID: 2-s2.0-85205564123 10/07/2024

  • (Steineck A, Silbert SK, Palm K, Nepper J, Vaughn D, Shipman K, Shalabi H, Wiener L, Comiskey L, Knight JM, Levine D.) Pediatr Blood Cancer. 2024 Sep;71(9):e31092 PMID: 38867358 PMCID: PMC11269012 SCOPUS ID: 2-s2.0-85195666643 06/13/2024

  • (Turcotte LM, Wang T, Beyer KM, Cole SW, Spellman SR, Allbee-Johnson M, Williams E, Zhou Y, Verneris MR, Rizzo JD, Knight JM.) Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2404108121 PMID: 39008669 PMCID: PMC11287259 SCOPUS ID: 2-s2.0-85199015473 07/15/2024

  • (Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, Ballen K, Abid MB, Diaz Perez MA, Al-Homsi AS, Hashem H, Hong S, Munker R, Schears RM, Lazarus HM, Ciurea S, Badawy SM, Savani BN, Wirk B, LeMaistre CF, Bhatt NS, Beitinjaneh A, Aljurf M, Sharma A, Cerny J, Knight JM, Kelkar AH, Yared JA, Kindwall-Keller T, Winestone LE, Steinberg A, Arnold SD, Seo S, Preussler JM, Hossain NM, Fingrut WB, Agrawal V, Hashmi S, Lehmann LE, Wood WA, Rangarajan HG, Saber W, Hahn T.) Blood Adv. 2024 Jul 09;8(13):3497-3506 PMID: 38661372 PMCID: PMC11260842 SCOPUS ID: 2-s2.0-85198087831 04/25/2024

  • (Awoyinka I, Tovar M, Young S, Beyer K, Kwarteng J, Knight J, Stolley M.) Support Care Cancer. 2024 Feb 21;32(3):178 PMID: 38381216 SCOPUS ID: 2-s2.0-85185668818 02/21/2024

  • (Bird CM, Kate Webb E, Cole SW, Tomas CW, Knight JM, Timmer-Murillo SC, Larson CL, deRoon-Cassini TA, Torres L.) Brain Behav Immun. 2024 Feb;116:229-236 PMID: 38070623 PMCID: PMC10872243 SCOPUS ID: 2-s2.0-85180086979 12/10/2023

  • (Lahijani S, Rueda-Lara M, McAndrew N, Nelson AM, Guo M, Knight JM, Wiener L, Miran DM, Gray TF, Keane EP, Yek MH, Sannes TS, Applebaum AJ, Fank P, Babu P, Pozo-Kaderman C, Amonoo HL.) Transplantation and Cellular Therapy. September 2024;30(9):S493-S512 SCOPUS ID: 2-s2.0-85205564123 09/01/2024

  • (Taylor MR, Cole SW, Strom J, Brazauskas R, Baker KS, Phelan R, Buchbinder D, Hamilton B, Schoemans H, Shaw BE, Sharma A, Bhatt NS, Badawy SM, Winestone LE, Preussler JM, Mayo S, Jamani K, Nishihori T, Lee MA, Knight JM.) Blood Adv. 2023 Nov 28;7(22):6830-6838 PMID: 37773924 PMCID: PMC10679811 SCOPUS ID: 2-s2.0-85178332888 09/29/2023

  • (Blue BJ, Brazauskas R, Chen K, Patel J, Zeidan AM, Steinberg A, Ballen K, Kwok J, Rotz SJ, Perez MAD, Kelkar AH, Ganguly S, Wingard JR, Lad D, Sharma A, Badawy SM, Lazarus HM, Hashem H, Szwajcer D, Knight JM, Bhatt NS, Page K, Beattie S, Arai Y, Liu H, Arnold SD, Freytes CO, Abid MB, Beitinjaneh A, Farhadfar N, Wirk B, Winestone LE, Agrawal V, Preussler JM, Seo S, Hashmi S, Lehmann L, Wood WA, Rangarajan HG, Saber W, Majhail NS.) Transplant Cell Ther. 2023 Nov;29(11):709.e1-709.e11 PMID: 37482244 PMCID: PMC11258715 SCOPUS ID: 2-s2.0-85173143416 07/24/2023

  • (Cusatis R, Ibrahim A, Knight JM, D'Souza A, Shaw BE.) Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):366-369 PMID: 37363976 SCOPUS ID: 2-s2.0-85163346266 06/26/2023

Publications of from the

© 2024 91九色视频.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.